Literature DB >> 18223458

Characterization of the inosine triphosphatase (ITPA) gene: haplotype structure, haplotype-phenotype correlation and promoter function.

Nicolas von Ahsen1, Michael Oellerich, Victor W Armstrong.   

Abstract

Inosine triphosphatase (ITPA) cleaves phosphate residues from inosine triphosphate (ITP) and deoxy ITP (dITP), thereby recovering inosine monophosphate, which is a substrate for further purine nucleotide pathways. Deficient ITPA activity leads to intracellular accumulation of ITP/dITP and would, under thiopurine therapy, lead to accumulation of unusual thio-inosine metabolites (thio-ITP) with the potential for adverse metabolic effects. ITPA is a promising candidate for a more comprehensive understanding of thiopurine pharmacogenetics. We therefore studied the haplotype structure, haplotype-phenotype association, and promoter function of ITPA in a Western European population.ITPA haplotyping was performed based on haplotype tagging SNPs (selected from HapMap data) in healthy 130 controls. Haplotypes were reconstructed, and the haplotype-phenotype association was assessed by haplotype trend regression. A 1.5 kb upstream region and stepwise deletions thereof were tested for promoter activity in reporter gene assays in HepG2 and CCRF-CEM cells. Transcription factor binding (Sp1, Sp3) to the proximal promoter region was studied by chromatin immunoprecipitation. Among haplotypes with a frequency greater than 0.01, we did not find any new low-activity haplotypes besides those carrying 94C>A or IVS2 + 21A>C variants. Two promoter SNPs had no influence on promoter activity. An approximately 200 bp sized GC-rich proximal promoter region was sufficient to fully drive reporter gene activity. Chromatin immunoprecipitation showed binding of Sp1 and Sp3 transcription factors to this region. Only the two haplotypes carrying 94C>A or IVS2 + 21A>C were associated with reduced enzyme activity. The gene promoter is associated with a CpG island and driven by Sp-family transcription factors. There was no evidence for functional promoter SNPs, and it is suggested that only SNPs within the very proximal promoter region (approximately 200 bp) have the potential to be functionally significant.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18223458     DOI: 10.1097/FTD.0b013e318161a21a

Source DB:  PubMed          Journal:  Ther Drug Monit        ISSN: 0163-4356            Impact factor:   3.681


  7 in total

1.  Epistatic interactions between thiopurine methyltransferase (TPMT) and inosine triphosphate pyrophosphatase (ITPA) variations determine 6-mercaptopurine toxicity in Indian children with acute lymphoblastic leukemia.

Authors:  Patchva Dorababu; Narayana Nagesh; Vijay Gandhi Linga; Sadashivudu Gundeti; Vijay Kumar Kutala; Pallu Reddanna; Raghunadharao Digumarti
Journal:  Eur J Clin Pharmacol       Date:  2011-10-19       Impact factor: 2.953

2.  Functional study of the P32T ITPA variant associated with drug sensitivity in humans.

Authors:  Elena I Stepchenkova; Elena R Tarakhovskaya; Kathryn Spitler; Christin Frahm; Miriam R Menezes; Peter D Simone; Carol Kolar; Luis A Marky; Gloria E O Borgstahl; Youri I Pavlov
Journal:  J Mol Biol       Date:  2009-07-23       Impact factor: 5.469

Review 3.  Pharmacogenetic determinants of mercaptopurine disposition in children with acute lymphoblastic leukemia.

Authors:  Tiphaine Adam de Beaumais; Evelyne Jacqz-Aigrain
Journal:  Eur J Clin Pharmacol       Date:  2012-03-16       Impact factor: 2.953

4.  A facile PCR-RFLP method for genotyping of ITPA rs1127354 and rs7270101 polymorphisms.

Authors:  Seyed Ehsan Alavian; Heidar Sharafi; Paniz Shirmast; Seyed Moayed Alavian; Bita Behnava; Mohammad Pouryasin; Maryam Keshvari; Ali Pouryasin
Journal:  J Clin Lab Anal       Date:  2018-04-16       Impact factor: 2.352

5.  Genetic polymorphism of inosine triphosphate pyrophosphatase is a determinant of mercaptopurine metabolism and toxicity during treatment for acute lymphoblastic leukemia.

Authors:  G Stocco; M H Cheok; K R Crews; T Dervieux; D French; D Pei; W Yang; C Cheng; C-H Pui; M V Relling; W E Evans
Journal:  Clin Pharmacol Ther       Date:  2008-08-06       Impact factor: 6.875

6.  TPMT but not ITPA gene polymorphism influences the risk of azathioprine intolerance in renal transplant recipients.

Authors:  Mateusz Kurzawski; Krzysztof Dziewanowski; Agnieszka Lener; Marek Drozdzik
Journal:  Eur J Clin Pharmacol       Date:  2009-02-20       Impact factor: 2.953

7.  Multilocus genotypes of relevance for drug metabolizing enzymes and therapy with thiopurines in patients with acute lymphoblastic leukemia.

Authors:  Gabriele Stocco; Raffaella Franca; Federico Verzegnassi; Margherita Londero; Marco Rabusin; Giuliana Decorti
Journal:  Front Genet       Date:  2013-01-07       Impact factor: 4.599

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.